A-kinase anchoring protein (AKAP) inhibitors are a class of chemical compounds designed to specifically target and disrupt the function of AKAPs, which are a family of scaffold proteins that play a crucial role in the spatial and temporal regulation of cellular signaling. AKAPs facilitate the organization of signaling complexes by anchoring protein kinase A (PKA) and other signaling molecules to specific subcellular locations, such as the plasma membrane, mitochondria, or cytoskeleton. This localization ensures that PKA and its associated signaling partners are precisely positioned to respond to localized cAMP signals, thereby enabling targeted phosphorylation of substrates involved in processes like metabolism, gene expression, and cell motility. By inhibiting AKAPs, researchers can disrupt the assembly and localization of these signaling complexes, leading to altered signaling dynamics within the cell.
In research settings, AKAP inhibitors are valuable tools for studying the spatial regulation of signal transduction and the broader implications of compartmentalized signaling on cellular function. By blocking AKAP activity, scientists can investigate how the disruption of these scaffold proteins affects PKA signaling and the downstream pathways that depend on precise localization of signaling components. This inhibition allows researchers to explore the role of AKAPs in coordinating complex signaling events, such as those involved in cellular responses to hormonal stimulation, stress, and changes in the extracellular environment. Additionally, AKAP inhibitors enable the study of the interactions between AKAPs and other signaling molecules, providing insights into the molecular mechanisms that underlie the formation of signaling complexes and the regulation of their activity. Through these studies, the use of AKAP inhibitors enhances our understanding of the importance of spatial organization in cellular signaling, the role of scaffold proteins in maintaining signaling fidelity, and the broader consequences of disrupted signaling compartmentalization on cellular processes.
Items 1 to 10 of 11 total
展示:
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | ¥2414.00 ¥3565.00 ¥4716.00 | 7 | |
5-氮杂-2′-脱氧胞苷(地西他滨)可通过引起AKAP9基因启动子的低甲基化,导致转录物抑制,从而降低AKAP9的表达。 | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | ¥1467.00 ¥3046.00 | 37 | |
5-Aza-2′-Deoxycytidine (Vorinostat) 可通过增加 AKAP9 基因附近组蛋白的乙酰化来下调 AKAP9,从而改变染色质结构,使其处于不利于基因表达的状态。 | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | ¥1681.00 ¥5303.00 ¥6995.00 ¥13527.00 ¥23579.00 | 33 | |
通过抑制组蛋白去乙酰化酶的活性,Trichostatin A 可能会导致 AKAP9 基因位点的染色质过度乙酰化,从而导致表达量减少。 | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | ¥699.00 ¥1749.00 ¥3610.00 | 233 | |
雷帕霉素(西罗莫司)可以通过抑制 mTOR 信号来下调 AKAP9,而 mTOR 信号对许多基因的转录启动至关重要。 | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | ¥1365.00 ¥4423.00 | 148 | |
LY 294002 可通过抑制 PI3K/Akt 通路来减少 AKAP9 的表达,而 PI3K/Akt 通路与包括基因表达在内的各种细胞过程的控制有关。 | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | ¥406.00 ¥1681.00 | 11 | |
氟尿嘧啶可以通过破坏 RNA 的合成,从而阻碍 AKAP9 基因的转录过程,从而降低 AKAP9 的表达。 | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | ¥733.00 ¥3599.00 ¥6487.00 ¥11259.00 | 28 | |
维甲酸可能会通过激活AKAP9的核受体来下调AKAP9,AKAP9的核受体可与靶基因启动子中的维甲酸反应元件结合,包括潜在的AKAP9,从而导致转录抑制。 | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | ¥1038.00 ¥2358.00 | 33 | |
甲氨蝶呤可通过干扰叶酸代谢来抑制 AKAP9 的表达,而叶酸是合成核苷酸进而转录基因所必需的。 | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | ¥857.00 ¥2877.00 | 18 | |
羟基脲可能会通过抑制核糖核苷酸还原酶来降低 AKAP9 的表达水平,而核糖核苷酸还原酶是 DNA 合成和后续基因转录过程所必需的。 | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | ¥643.00 ¥1049.00 ¥2708.00 ¥8044.00 | 8 | |
鞣花酸可能通过抑制 NF-kB 的 DNA 结合活性来下调 AKAP9,NF-kB 可抑制某些基因的转录,可能包括 AKAP9。 |